TriSalus Life Sciences (TLSI) Competitors $5.74 +0.01 (+0.17%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$5.74 +0.00 (+0.09%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLSI vs. IRMD, AVNS, SIBN, KIDS, BFLY, TMCI, BBNX, NPCE, DCTH, and SMLRShould you be buying TriSalus Life Sciences stock or one of its competitors? The main competitors of TriSalus Life Sciences include Iradimed (IRMD), Avanos Medical (AVNS), SI-BONE (SIBN), OrthoPediatrics (KIDS), Butterfly Network (BFLY), Treace Medical Concepts (TMCI), Beta Bionics (BBNX), NeuroPace (NPCE), Delcath Systems (DCTH), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. TriSalus Life Sciences vs. Iradimed Avanos Medical SI-BONE OrthoPediatrics Butterfly Network Treace Medical Concepts Beta Bionics NeuroPace Delcath Systems Semler Scientific TriSalus Life Sciences (NASDAQ:TLSI) and Iradimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability. Do analysts prefer TLSI or IRMD? TriSalus Life Sciences currently has a consensus price target of $11.56, indicating a potential upside of 101.44%. Iradimed has a consensus price target of $72.00, indicating a potential upside of 39.08%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe TriSalus Life Sciences is more favorable than Iradimed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.20Iradimed 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, TLSI or IRMD? TriSalus Life Sciences has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Comparatively, Iradimed has a beta of 0.82, suggesting that its stock price is 18% less volatile than the S&P 500. Do insiders & institutionals have more ownership in TLSI or IRMD? 2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 92.3% of Iradimed shares are held by institutional investors. 32.8% of TriSalus Life Sciences shares are held by insiders. Comparatively, 37.1% of Iradimed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor TLSI or IRMD? In the previous week, Iradimed had 6 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 6 mentions for Iradimed and 0 mentions for TriSalus Life Sciences. Iradimed's average media sentiment score of 1.37 beat TriSalus Life Sciences' score of 0.00 indicating that Iradimed is being referred to more favorably in the news media. Company Overall Sentiment TriSalus Life Sciences Neutral Iradimed Positive Is TLSI or IRMD more profitable? Iradimed has a net margin of 26.26% compared to TriSalus Life Sciences' net margin of -206.24%. Iradimed's return on equity of 24.12% beat TriSalus Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets TriSalus Life Sciences-206.24% N/A -236.83% Iradimed 26.26%24.12%21.20% Does the MarketBeat Community favor TLSI or IRMD? Iradimed received 245 more outperform votes than TriSalus Life Sciences when rated by MarketBeat users. However, 100.00% of users gave TriSalus Life Sciences an outperform vote while only 65.40% of users gave Iradimed an outperform vote. CompanyUnderperformOutperformTriSalus Life SciencesOutperform Votes14100.00% Underperform VotesNo VotesIradimedOutperform Votes25965.40% Underperform Votes13734.60% Which has better valuation & earnings, TLSI or IRMD? Iradimed has higher revenue and earnings than TriSalus Life Sciences. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTriSalus Life Sciences$29.43M5.95-$59.04M-$1.33-4.32Iradimed$73.24M8.99$19.23M$1.5034.51 SummaryIradimed beats TriSalus Life Sciences on 14 of the 19 factors compared between the two stocks. Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSI vs. The Competition Export to ExcelMetricTriSalus Life SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$175.03M$4.04B$5.30B$7.34BDividend YieldN/A39.51%5.12%4.30%P/E Ratio-2.3127.6821.8017.77Price / Sales5.9547.08379.9097.68Price / CashN/A51.0838.2634.64Price / Book-5.865.816.443.98Net Income-$59.04M$67.09M$3.21B$247.52M7 Day Performance4.17%1.98%2.84%1.82%1 Month Performance12.55%-4.83%-8.65%-6.98%1 Year Performance-41.61%14.48%11.38%1.49% TriSalus Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSITriSalus Life Sciences2.7992 of 5 stars$5.74+0.2%$11.56+101.4%-40.9%$175.03M$29.43M-2.31106IRMDIradimed4.8742 of 5 stars$49.37-1.1%$72.00+45.8%+27.9%$627.74M$73.24M32.91110Short Interest ↓Positive NewsGap DownAVNSAvanos Medical3.2251 of 5 stars$12.88-4.0%N/A-33.7%$617.36M$687.80M37.884,040High Trading VolumeSIBNSI-BONE4.1653 of 5 stars$13.47flat$24.40+81.1%-9.1%$571.84M$167.18M-14.64350Positive NewsGap DownKIDSOrthoPediatrics4.3251 of 5 stars$21.80-4.0%$37.20+70.6%-29.8%$529.46M$204.73M-17.72200High Trading VolumeBFLYButterfly Network2.4691 of 5 stars$2.08+1.7%$3.00+44.6%+185.0%$504.07M$82.06M-4.51460News CoveragePositive NewsGap UpTMCITreace Medical Concepts2.8467 of 5 stars$7.61-1.8%$10.14+33.3%-43.5%$476.53M$209.36M-7.69250News CoverageGap DownBBNXBeta BionicsN/A$10.44+5.3%$24.83+137.9%N/A$452.56M$65.12M0.00294Gap DownNPCENeuroPace2.8494 of 5 stars$12.30+0.6%$15.20+23.6%-21.5%$400.49M$79.91M-12.30170Short Interest ↑Gap DownDCTHDelcath Systems2.9672 of 5 stars$10.91-0.9%$22.75+108.5%+159.9%$364.43M$37.21M-8.0860Positive NewsGap DownSMLRSemler Scientific2.3696 of 5 stars$34.15+0.9%$71.00+107.9%+26.6%$327.74M$56.29M6.96120Short Interest ↑ Related Companies and Tools Related Companies Iradimed Competitors Avanos Medical Competitors SI-BONE Competitors OrthoPediatrics Competitors Butterfly Network Competitors Treace Medical Concepts Competitors Beta Bionics Competitors NeuroPace Competitors Delcath Systems Competitors Semler Scientific Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLSI) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TLSI Stock Free TLSI Stock Alerts